Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals.
Open Access
- 1 December 1994
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 481 (2) , 407-414
- https://doi.org/10.1113/jphysiol.1994.sp020449
Abstract
1. In addition to nitric oxide (NO) and prostacyclin (PGI2) an as yet unidentified endothelium‐derived hyperpolarizing factor (EDHF) contributes to the dilator effect of bradykinin in different vascular beds. We have investigated the nature and mechanism of action of this factor in freshly isolated bovine and porcine coronary artery segments which were preconstricted with the thromboxane mimetic U46619 (9,11‐dideoxy‐11 alpha, 9 alpha‐epoxymethano‐prostaglandin F2 alpha, 10‐30 nM). 2. The concentration‐response curve of bradykinin was significantly shifted to the right after inhibition of NO synthesis with NG‐nitro‐L‐arginine (L‐NNA, 30 microM), whereas cyclo‐oxygenase blockade with diclofenac (1 microM) had no effect. Preconstriction of the segments with potassium chloride (40‐60 mM) completely abrogated the NO/PGI2‐independent dilator response to bradykinin. In sandwich bioassay experiments, both the luminal and abluminal release of NO, but not that of EDHF, was readily detectable. 3. Inhibitors of Ca(2+)‐activated K+ channels (K+Ca), such as apamin (1 microM) and tetrabutylammonium (TBA, 3 mM), strongly attenuated the EDHF‐mediated bradykinin‐induced relaxation, while glibenclamide (3 microM), an inhibitor of K+ATP channels, had no effect. 4. These relaxations were also significantly inhibited by the phospholipase A2 inhibitor, quinacrine (30 microM), and the cytochrome P450 inhibitors, SKF525a (30‐100 microM) and clotrimazole (100 microM). Moreover, incubation of endothelium‐denuded coronary artery rings with a cytochrome P450‐derived arachidonic acid metabolite, 11,12‐epoxyeicosatetraenoic acid, elicited a concentration‐dependent (1‐10 microM) dilatation which was abolished both in the presence of TBA (3 mM) and following preconstriction of the segments with potassium chloride instead of U46619.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 21 references indexed in Scilit:
- Pharmacologic Differentiation Between Endothelium-Dependent Relaxations Sensitive and Resistant to Nitro-L-Arginine in Coronary ArteriesJournal of Cardiovascular Pharmacology, 1994
- Bidirectional electrical communication between smooth muscle and endothelial cells in the pig coronary arteryAmerican Journal of Physiology-Heart and Circulatory Physiology, 1994
- Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.Journal of Clinical Investigation, 1993
- Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acidAmerican Journal of Physiology-Heart and Circulatory Physiology, 1993
- Effect of nitro‐L‐arginine on endothelium‐dependent hyperpolarizations and relaxations of pig coronary arteries.The Journal of Physiology, 1992
- Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studiesBritish Journal of Pharmacology, 1991
- ARACHIDONIC ACID-INDUCED ENDOTHELIAL-DEPENDENT RELAXATIONS OF CANINE CORONARY-ARTERIES - CONTRIBUTION OF A CYTOCHROME P-450-DEPENDENT PATHWAY1987
- Single apamin-blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscleNature, 1986
- Some electrical and pharmacological properties of gap junctions between adult ventricular myocytesAmerican Journal of Physiology-Cell Physiology, 1985
- Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscleNature, 1985